母体免疫激活延迟子代兴奋性向抑制性GABA转换
该研究在妊娠第9天给孕鼠腹腔注射polyinosinic:polycytidylic acid以模拟母体免疫激活,通过电生理、光学和生化分析评估子代神经元发育。结果发现产前暴露导致Na+-K+-2Cl-共转运体1与K+-Cl-共转运体2(KCC2)表达失衡,延迟GABA转换并增加癫痫易感性至成年;机制涉及RE1沉默转录因子结合KCC2启动子509位点下调转录,而镁硫酸盐预处理可预防该炎症状态和转换延迟。
要点
- 产前polyinosinic:polycytidylic acid暴露致子代KCC2/NKCC1失衡和GABA转换延迟。
- 该延迟伴随癫痫易感性增高并持续至成年。
- 孕鼠镁硫酸盐预处理可预防炎症状态和GABA转换延迟。
核心结论
- 母体免疫激活作用于关键神经发育过程即兴奋性向抑制性GABA转换,其缺陷与自闭症谱系障碍或癫痫等疾病明确相关。
研究设计与样本
- 孕鼠在妊娠第9天腹腔注射polyinosinic:polycytidylic acid,子代神经元发育通过电生理、光学和生化分析评估。
主要发现
- 产前polyinosinic:polycytidylic acid暴露导致Na+-K+-2Cl-共转运体1和KCC2表达失衡,延迟GABA转换并增加癫痫易感性至成年。
- 染色质免疫沉淀显示RE1沉默转录因子与KCC2启动子509位点结合增加,导致KCC2转录下调。
- 白细胞介素-1受体I型敲除小鼠在野生型母鼠中孕期暴露后不显示KCC2/Na+-K+-2Cl-共转运体1失衡。
- 孕鼠镁硫酸盐预处理足以预防母体免疫激活相关的早期炎症状态和兴奋性向抑制性转换延迟。
关键数值与推荐
- 产前暴露子代中KCC2启动子509位点RE1沉默转录因子结合增加导致KCC2转录下调。
临床怎么用
- 提示镁硫酸盐预处理可能作为安全药物治疗,在特定妊娠时间窗预防产前免疫激活所致神经发育缺陷。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The association between maternal infection and neurodevelopmental defects in progeny is well established, although the biological mechanisms and the pathogenic trajectories involved have not been defined. METHODS: Pregnant dams were injected intraperitoneally at gestational day 9 with polyinosinic:polycytidylic acid. Neuronal development was assessed by means of electrophysiological, optical, and biochemical analyses. RESULTS: Prenatal exposure to polyinosinic:polycytidylic acid causes an imbalanced expression of the Na+-K+-2Cl- cotransporter 1 and the K+-Cl- cotransporter 2 (KCC2). This results in delayed gamma-aminobutyric acid switch and higher susceptibility to seizures, which endures up to adulthood. Chromatin immunoprecipitation experiments reveal increased binding of the repressor factor RE1-silencing transcription (also known as neuron-restrictive silencer factor) to position 509 of the KCC2 promoter that leads to downregulation of KCC2 transcription in prenatally exposed offspring. Interleukin-1 receptor type I knockout mice, which display braked immune response and no brain cytokine elevation upon maternal immune activation, do not display KCC2/Na+-K+-2Cl- cotransporter 1 imbalance when implanted in a wild-type dam and prenatally exposed. Notably, pretreatment of pregnant dams with magnesium sulfate is sufficient to prevent the early inflammatory state and the delay in excitatory-to-inhibitory switch associated to maternal immune activation. CONCLUSIONS: We provide evidence that maternal immune activation hits a key neurodevelopmental process, the excitatory-to-inhibitory gamma-aminobutyric acid switch; defects in this switch have been unequivocally linked to diseases such as autism spectrum disorder or epilepsy. These data open the avenue for a safe pharmacological treatment that may prevent the neurodevelopmental defects caused by prenatal immune activation in a specific pregnancy time window.
引用
- Corradini I, Focchi E, Rasile M, et al. Maternal Immune Activation Delays Excitatory-to-Inhibitory Gamma-Aminobutyric Acid Switch in Offspring. Biol Psychiatry. 2017. PMID: 29146047. doi:10.1016/j.biopsych.2017.09.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。